| Trial ID: | L2923 |
| Source ID: | NCT01677104
|
| Associated Drug: |
Glp-1
|
| Title: |
The Microvascular Function of GLP-1 and Its Analogues
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Obesity
|
| Interventions: |
DRUG: GLP-1|DRUG: Placebo
|
| Outcome Measures: |
Primary: skin blood flow, skin blood flow will be assessed before and after microinjection of GLP-1 or its analogues and the injection site monitored and compared to sites injected with placebo, 3 hours |
|
| Sponsor/Collaborators: |
Sponsor: Katarina Kos | Collaborators: Diabetes UK
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
63
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2012-08
|
| Completion Date: |
2014-07
|
| Results First Posted: |
|
| Last Update Posted: |
2017-04-13
|
| Locations: |
Diabetes and Vascular Center, Exeter, EX2 5AX, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT01677104
|
